A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for Advanced Solid Tumor
13 locations incl. Jacksonville
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05932862·Phase 1·Recruiting·Listed Jul 2023
Clinical research site in Oklahoma City, Oklahoma · 1515 SE 44TH ST, OKLAHOMA CITY, OK 73129-7906 · (405) 371-0212
Part of Exelixis Clinical
As of July 2026, 1 paid clinical trial is recruiting at Exelixis Clinical in Oklahoma City, Oklahoma. Active studies at this site focus on Advanced Solid Tumor alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Oklahoma City, OK · Oklahoma clinical trials